| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Selenoproteins | 30 | 2024 | 159 | 10.440 |
Why?
|
| Selenium | 20 | 2023 | 148 | 5.780 |
Why?
|
| T-Lymphocytes | 6 | 2022 | 357 | 2.670 |
Why?
|
| Mice | 58 | 2024 | 5913 | 2.560 |
Why?
|
| Lymphocyte Activation | 6 | 2024 | 236 | 2.370 |
Why?
|
| Phospholipids | 3 | 2022 | 70 | 2.300 |
Why?
|
| Animals | 82 | 2024 | 15081 | 2.130 |
Why?
|
| Calpain | 5 | 2021 | 35 | 1.920 |
Why?
|
| Calcium Signaling | 5 | 2019 | 101 | 1.790 |
Why?
|
| Mice, Knockout | 17 | 2024 | 933 | 1.630 |
Why?
|
| Epithelial Cells | 6 | 2011 | 384 | 1.580 |
Why?
|
| Proteomics | 8 | 2022 | 325 | 1.580 |
Why?
|
| Ethanolamine | 2 | 2021 | 8 | 1.570 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 6 | 2020 | 103 | 1.570 |
Why?
|
| Colitis | 5 | 2017 | 65 | 1.510 |
Why?
|
| Proteome | 8 | 2020 | 144 | 1.450 |
Why?
|
| Cell Differentiation | 8 | 2024 | 587 | 1.430 |
Why?
|
| Homeostasis | 3 | 2024 | 188 | 1.420 |
Why?
|
| Ovarian Neoplasms | 8 | 2017 | 312 | 1.390 |
Why?
|
| Mice, Inbred C57BL | 24 | 2024 | 1609 | 1.350 |
Why?
|
| Lipoylation | 4 | 2016 | 14 | 1.320 |
Why?
|
| Macrophages | 8 | 2016 | 439 | 1.300 |
Why?
|
| Endoplasmic Reticulum | 8 | 2021 | 105 | 1.200 |
Why?
|
| Neoplasm Proteins | 3 | 2019 | 213 | 1.180 |
Why?
|
| Humans | 76 | 2024 | 37093 | 1.100 |
Why?
|
| Immune System Diseases | 2 | 2018 | 21 | 1.050 |
Why?
|
| Neoplasms | 4 | 2019 | 1103 | 1.050 |
Why?
|
| Selenocysteine | 3 | 2022 | 55 | 1.050 |
Why?
|
| Intestinal Mucosa | 5 | 2014 | 122 | 1.050 |
Why?
|
| Transforming Growth Factor alpha | 3 | 2010 | 22 | 1.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 2 | 2015 | 9 | 1.020 |
Why?
|
| Antioxidants | 3 | 2014 | 416 | 1.000 |
Why?
|
| Ethanolaminephosphotransferase | 2 | 2021 | 4 | 1.000 |
Why?
|
| Cell Proliferation | 12 | 2021 | 1198 | 0.990 |
Why?
|
| Lipopolysaccharides | 3 | 2024 | 220 | 0.980 |
Why?
|
| Phagocytosis | 4 | 2016 | 69 | 0.980 |
Why?
|
| Disease Models, Animal | 10 | 2024 | 1371 | 0.980 |
Why?
|
| Colonic Neoplasms | 2 | 2017 | 186 | 0.970 |
Why?
|
| Calcitonin Gene-Related Peptide | 3 | 2010 | 11 | 0.970 |
Why?
|
| Substance P | 3 | 2010 | 26 | 0.960 |
Why?
|
| Inflammation | 5 | 2018 | 618 | 0.950 |
Why?
|
| Oligodendroglia | 1 | 2024 | 24 | 0.950 |
Why?
|
| Immunoglobulin M | 1 | 2024 | 82 | 0.940 |
Why?
|
| Colon | 5 | 2017 | 103 | 0.940 |
Why?
|
| Myelin Sheath | 1 | 2024 | 48 | 0.940 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 185 | 0.900 |
Why?
|
| Lipid Metabolism | 1 | 2024 | 119 | 0.890 |
Why?
|
| CA-125 Antigen | 2 | 2012 | 9 | 0.860 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2022 | 6 | 0.860 |
Why?
|
| Fibroblasts | 3 | 2010 | 272 | 0.840 |
Why?
|
| Calcium-Binding Proteins | 2 | 2013 | 76 | 0.830 |
Why?
|
| Calcium | 4 | 2016 | 480 | 0.820 |
Why?
|
| Cell Movement | 10 | 2021 | 571 | 0.810 |
Why?
|
| Serum Albumin | 2 | 2019 | 50 | 0.810 |
Why?
|
| NF-kappa B | 6 | 2017 | 339 | 0.780 |
Why?
|
| Stomach Neoplasms | 2 | 2014 | 195 | 0.770 |
Why?
|
| Metabolism | 1 | 2020 | 9 | 0.760 |
Why?
|
| Immunity, Cellular | 2 | 2014 | 70 | 0.760 |
Why?
|
| Cytoskeletal Proteins | 2 | 2019 | 105 | 0.760 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2019 | 92 | 0.740 |
Why?
|
| Wound Healing | 4 | 2011 | 70 | 0.740 |
Why?
|
| Interferon-gamma | 5 | 2018 | 250 | 0.740 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 169 | 0.730 |
Why?
|
| Macrophage Activation | 3 | 2015 | 56 | 0.720 |
Why?
|
| Lenses, Intraocular | 3 | 2024 | 6 | 0.720 |
Why?
|
| Immunity | 2 | 2012 | 53 | 0.720 |
Why?
|
| gamma-Globulins | 1 | 2019 | 5 | 0.720 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2019 | 93 | 0.710 |
Why?
|
| Keratin-5 | 2 | 2017 | 8 | 0.710 |
Why?
|
| Blastocyst | 1 | 2020 | 48 | 0.710 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2015 | 159 | 0.700 |
Why?
|
| Mast Cells | 4 | 2014 | 81 | 0.690 |
Why?
|
| Receptors, IgG | 3 | 2016 | 50 | 0.680 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2020 | 286 | 0.660 |
Why?
|
| Immune System | 1 | 2018 | 41 | 0.640 |
Why?
|
| Asthma | 4 | 2011 | 380 | 0.640 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2008 | 93 | 0.640 |
Why?
|
| Phosphatidylethanolamines | 3 | 2024 | 27 | 0.630 |
Why?
|
| Acyltransferases | 2 | 2015 | 21 | 0.630 |
Why?
|
| Cardiovascular System | 2 | 2016 | 33 | 0.620 |
Why?
|
| Mesothelioma | 3 | 2015 | 144 | 0.610 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2015 | 32 | 0.610 |
Why?
|
| Cancer Vaccines | 2 | 2015 | 21 | 0.610 |
Why?
|
| Vaccines, DNA | 2 | 2015 | 23 | 0.610 |
Why?
|
| Paracrine Communication | 2 | 2007 | 15 | 0.600 |
Why?
|
| Neoplasm Metastasis | 3 | 2017 | 219 | 0.590 |
Why?
|
| Selenoprotein P | 2 | 2007 | 50 | 0.580 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2016 | 12 | 0.570 |
Why?
|
| Vulvar Neoplasms | 1 | 2016 | 12 | 0.560 |
Why?
|
| MicroRNAs | 1 | 2022 | 426 | 0.550 |
Why?
|
| Diet | 5 | 2014 | 801 | 0.550 |
Why?
|
| Rats | 13 | 2020 | 3483 | 0.550 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2014 | 88 | 0.540 |
Why?
|
| Stress, Physiological | 2 | 2014 | 150 | 0.530 |
Why?
|
| Female | 29 | 2024 | 20969 | 0.530 |
Why?
|
| Male | 22 | 2024 | 20025 | 0.510 |
Why?
|
| Oligopeptides | 1 | 2015 | 102 | 0.510 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 251 | 0.500 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 178 | 0.490 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2014 | 259 | 0.480 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2015 | 173 | 0.480 |
Why?
|
| RNA, Messenger | 9 | 2015 | 1207 | 0.480 |
Why?
|
| Phacoemulsification | 2 | 2024 | 9 | 0.480 |
Why?
|
| Antineoplastic Agents | 3 | 2018 | 803 | 0.480 |
Why?
|
| Up-Regulation | 4 | 2024 | 513 | 0.470 |
Why?
|
| Fumarates | 1 | 2014 | 11 | 0.470 |
Why?
|
| Renin | 1 | 2014 | 30 | 0.470 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2017 | 807 | 0.470 |
Why?
|
| Blotting, Western | 6 | 2015 | 859 | 0.460 |
Why?
|
| Signal Transduction | 9 | 2019 | 1908 | 0.460 |
Why?
|
| Micronutrients | 1 | 2014 | 44 | 0.460 |
Why?
|
| Gastrointestinal Diseases | 1 | 2014 | 42 | 0.450 |
Why?
|
| Amides | 1 | 2014 | 68 | 0.450 |
Why?
|
| Lung Neoplasms | 3 | 2014 | 358 | 0.450 |
Why?
|
| Lymph Nodes | 6 | 2021 | 67 | 0.440 |
Why?
|
| Oxidation-Reduction | 5 | 2022 | 431 | 0.430 |
Why?
|
| Neoplasms, Experimental | 1 | 2012 | 37 | 0.420 |
Why?
|
| Pyruvaldehyde | 2 | 2022 | 4 | 0.420 |
Why?
|
| Mice, Transgenic | 8 | 2020 | 617 | 0.410 |
Why?
|
| Ethanolamines | 2 | 2022 | 12 | 0.410 |
Why?
|
| Antigen-Antibody Complex | 1 | 2011 | 19 | 0.410 |
Why?
|
| Oxidative Stress | 3 | 2014 | 938 | 0.410 |
Why?
|
| Apoptosis | 8 | 2021 | 1398 | 0.410 |
Why?
|
| Cell Line | 10 | 2019 | 1354 | 0.400 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2011 | 56 | 0.400 |
Why?
|
| Myocardium | 2 | 2011 | 235 | 0.400 |
Why?
|
| Dendritic Cells | 4 | 2021 | 113 | 0.390 |
Why?
|
| Lymphotoxin-alpha | 1 | 2011 | 4 | 0.390 |
Why?
|
| Toll-Like Receptors | 1 | 2011 | 51 | 0.390 |
Why?
|
| Aging | 2 | 2014 | 664 | 0.390 |
Why?
|
| Cell Migration Inhibition | 1 | 2011 | 5 | 0.390 |
Why?
|
| Dietary Supplements | 2 | 2010 | 208 | 0.380 |
Why?
|
| Down-Regulation | 6 | 2017 | 435 | 0.380 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 284 | 0.380 |
Why?
|
| Mice, Inbred BALB C | 6 | 2015 | 661 | 0.380 |
Why?
|
| Bone Marrow Cells | 4 | 2014 | 81 | 0.370 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2016 | 421 | 0.360 |
Why?
|
| Carbachol | 1 | 2009 | 19 | 0.360 |
Why?
|
| Sulfhydryl Compounds | 1 | 2010 | 47 | 0.360 |
Why?
|
| Phosphoproteins | 3 | 2007 | 163 | 0.350 |
Why?
|
| Sensation | 1 | 2009 | 35 | 0.350 |
Why?
|
| Immunity, Innate | 3 | 2018 | 149 | 0.340 |
Why?
|
| Nitric Oxide | 1 | 2011 | 316 | 0.340 |
Why?
|
| Transfection | 3 | 2015 | 523 | 0.340 |
Why?
|
| Duodenum | 1 | 2008 | 12 | 0.330 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2021 | 67 | 0.330 |
Why?
|
| Epidermal Growth Factor | 1 | 2008 | 68 | 0.320 |
Why?
|
| Cytokines | 5 | 2018 | 602 | 0.320 |
Why?
|
| Transforming Growth Factor beta | 4 | 2011 | 197 | 0.310 |
Why?
|
| Lung | 3 | 2007 | 446 | 0.310 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 664 | 0.310 |
Why?
|
| Cells, Cultured | 9 | 2020 | 1518 | 0.310 |
Why?
|
| Central Nervous System | 2 | 2022 | 135 | 0.310 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2007 | 1 | 0.310 |
Why?
|
| Ileum | 1 | 2007 | 15 | 0.310 |
Why?
|
| Lymphocyte Subsets | 1 | 2007 | 21 | 0.300 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2007 | 16 | 0.300 |
Why?
|
| Cell Line, Tumor | 11 | 2017 | 2231 | 0.300 |
Why?
|
| Aged | 8 | 2019 | 6741 | 0.300 |
Why?
|
| Cystadenocarcinoma, Serous | 3 | 2017 | 35 | 0.300 |
Why?
|
| Flow Cytometry | 2 | 2014 | 399 | 0.300 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2015 | 623 | 0.300 |
Why?
|
| Phosphorylation | 8 | 2016 | 928 | 0.300 |
Why?
|
| Adaptive Immunity | 2 | 2018 | 27 | 0.290 |
Why?
|
| Selenomethionine | 2 | 2017 | 10 | 0.290 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 144 | 0.290 |
Why?
|
| Brain | 4 | 2024 | 1346 | 0.280 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 161 | 0.280 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2019 | 149 | 0.280 |
Why?
|
| Endothelium, Vascular | 2 | 2019 | 237 | 0.280 |
Why?
|
| Alzheimer Disease | 3 | 2020 | 905 | 0.280 |
Why?
|
| Neoplasm Staging | 3 | 2016 | 275 | 0.270 |
Why?
|
| Models, Biological | 3 | 2017 | 677 | 0.270 |
Why?
|
| Cell Nucleus | 3 | 2017 | 366 | 0.270 |
Why?
|
| Gene Expression Regulation | 6 | 2017 | 1015 | 0.270 |
Why?
|
| Prognosis | 3 | 2019 | 739 | 0.260 |
Why?
|
| Annexin A2 | 2 | 2016 | 6 | 0.260 |
Why?
|
| Electrophoresis | 1 | 2005 | 22 | 0.260 |
Why?
|
| Amino Acid Sequence | 9 | 2020 | 1180 | 0.250 |
Why?
|
| Phosphatidylserines | 1 | 2005 | 21 | 0.250 |
Why?
|
| HCT116 Cells | 2 | 2017 | 35 | 0.250 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 133 | 0.250 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 201 | 0.250 |
Why?
|
| Plasma Cells | 1 | 2024 | 10 | 0.250 |
Why?
|
| Multiprotein Complexes | 2 | 2015 | 54 | 0.240 |
Why?
|
| RNA, Viral | 2 | 2016 | 301 | 0.240 |
Why?
|
| Molecular Biology | 2 | 2015 | 46 | 0.240 |
Why?
|
| Transgenes | 2 | 2015 | 59 | 0.240 |
Why?
|
| Immunosuppressive Agents | 1 | 2005 | 76 | 0.240 |
Why?
|
| Plasmalogens | 1 | 2024 | 4 | 0.240 |
Why?
|
| Phospholipid Ethers | 1 | 2024 | 6 | 0.240 |
Why?
|
| Enzyme Activation | 4 | 2014 | 444 | 0.240 |
Why?
|
| Methionine Sulfoxide Reductases | 2 | 2014 | 2 | 0.240 |
Why?
|
| Culicidae | 1 | 2004 | 24 | 0.240 |
Why?
|
| Corneal Diseases | 1 | 2024 | 9 | 0.240 |
Why?
|
| Astigmatism | 1 | 2024 | 8 | 0.240 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 4 | 2015 | 78 | 0.240 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2024 | 11 | 0.240 |
Why?
|
| Glycolysis | 2 | 2022 | 68 | 0.240 |
Why?
|
| Genetic Vectors | 2 | 2015 | 158 | 0.240 |
Why?
|
| GTPase-Activating Proteins | 2 | 2016 | 29 | 0.230 |
Why?
|
| Middle Aged | 8 | 2019 | 10129 | 0.230 |
Why?
|
| Pseudoxanthoma Elasticum | 1 | 2024 | 32 | 0.230 |
Why?
|
| 14-3-3 Proteins | 2 | 2017 | 22 | 0.230 |
Why?
|
| Culture Media, Conditioned | 3 | 2008 | 46 | 0.230 |
Why?
|
| HT29 Cells | 2 | 2015 | 45 | 0.230 |
Why?
|
| Lipid Peroxidation | 1 | 2024 | 140 | 0.230 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2024 | 48 | 0.230 |
Why?
|
| Caco-2 Cells | 3 | 2008 | 52 | 0.230 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 409 | 0.230 |
Why?
|
| West Nile virus | 1 | 2004 | 65 | 0.230 |
Why?
|
| Disease Progression | 2 | 2017 | 601 | 0.230 |
Why?
|
| Peritoneal Neoplasms | 2 | 2015 | 16 | 0.220 |
Why?
|
| Biology | 1 | 2023 | 16 | 0.220 |
Why?
|
| Forkhead Transcription Factors | 2 | 2022 | 76 | 0.220 |
Why?
|
| Cytidine Diphosphate | 1 | 2022 | 4 | 0.220 |
Why?
|
| Schools, Medical | 2 | 2015 | 198 | 0.220 |
Why?
|
| Arsenic | 2 | 2022 | 144 | 0.210 |
Why?
|
| Ovalbumin | 3 | 2007 | 47 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 1039 | 0.210 |
Why?
|
| Phosphotransferases | 1 | 2022 | 35 | 0.210 |
Why?
|
| Molecular Sequence Data | 8 | 2016 | 1568 | 0.210 |
Why?
|
| Chromatids | 1 | 2022 | 3 | 0.210 |
Why?
|
| Mass Spectrometry | 6 | 2014 | 260 | 0.210 |
Why?
|
| Immunohistochemistry | 5 | 2016 | 893 | 0.210 |
Why?
|
| Interleukin-17 | 1 | 2022 | 53 | 0.210 |
Why?
|
| Tissue Distribution | 3 | 2014 | 207 | 0.210 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2022 | 14 | 0.210 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2022 | 28 | 0.210 |
Why?
|
| Serine | 2 | 2016 | 75 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2019 | 356 | 0.200 |
Why?
|
| Aged, 80 and over | 4 | 2016 | 2379 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 55 | 0.200 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 448 | 0.200 |
Why?
|
| 3' Untranslated Regions | 1 | 2022 | 74 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2020 | 1618 | 0.200 |
Why?
|
| Rats, Wistar | 2 | 2014 | 233 | 0.200 |
Why?
|
| Chemokine CCL21 | 1 | 2021 | 11 | 0.200 |
Why?
|
| Glutathione Peroxidase | 2 | 2014 | 111 | 0.190 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2021 | 21 | 0.190 |
Why?
|
| STAT6 Transcription Factor | 2 | 2013 | 16 | 0.190 |
Why?
|
| Lipogenesis | 1 | 2021 | 18 | 0.190 |
Why?
|
| Receptors, CCR | 1 | 2021 | 24 | 0.190 |
Why?
|
| Mice, Nude | 3 | 2017 | 337 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2017 | 259 | 0.190 |
Why?
|
| Synovial Membrane | 1 | 2020 | 4 | 0.190 |
Why?
|
| Cartilage, Articular | 1 | 2020 | 9 | 0.190 |
Why?
|
| Factor XIa | 1 | 2020 | 4 | 0.190 |
Why?
|
| Jurkat Cells | 4 | 2016 | 79 | 0.190 |
Why?
|
| Embryo Loss | 1 | 2020 | 5 | 0.190 |
Why?
|
| Osteoarthritis | 1 | 2020 | 20 | 0.180 |
Why?
|
| Metabolomics | 1 | 2021 | 81 | 0.180 |
Why?
|
| Antibodies, Monoclonal | 3 | 2017 | 290 | 0.180 |
Why?
|
| Adult | 8 | 2019 | 11712 | 0.180 |
Why?
|
| Homozygote | 1 | 2020 | 77 | 0.180 |
Why?
|
| Embryo Implantation | 1 | 2020 | 32 | 0.180 |
Why?
|
| Refraction, Ocular | 3 | 2024 | 29 | 0.180 |
Why?
|
| Gastrointestinal Agents | 1 | 2019 | 5 | 0.180 |
Why?
|
| Receptors, Steroid | 2 | 2017 | 36 | 0.180 |
Why?
|
| Embryonic Development | 1 | 2020 | 76 | 0.180 |
Why?
|
| Treatment Failure | 1 | 2019 | 64 | 0.180 |
Why?
|
| Phenotype | 1 | 2022 | 689 | 0.170 |
Why?
|
| Gene Deletion | 1 | 2020 | 166 | 0.170 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2020 | 137 | 0.170 |
Why?
|
| Capillary Permeability | 1 | 2019 | 30 | 0.170 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2019 | 2 | 0.170 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 974 | 0.170 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2019 | 9 | 0.170 |
Why?
|
| Animals, Newborn | 1 | 2020 | 343 | 0.170 |
Why?
|
| Dextran Sulfate | 2 | 2016 | 15 | 0.170 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2018 | 3 | 0.170 |
Why?
|
| Genome, Human | 1 | 2019 | 135 | 0.160 |
Why?
|
| Synapses | 1 | 2020 | 180 | 0.160 |
Why?
|
| Tumor Escape | 1 | 2018 | 13 | 0.160 |
Why?
|
| Cell Survival | 5 | 2019 | 864 | 0.160 |
Why?
|
| Leukocytes | 1 | 2018 | 72 | 0.160 |
Why?
|
| Administration, Oral | 2 | 2020 | 224 | 0.160 |
Why?
|
| Integrin beta3 | 1 | 2017 | 6 | 0.150 |
Why?
|
| Chorioallantoic Membrane | 1 | 2017 | 11 | 0.150 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2017 | 9 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2017 | 128 | 0.150 |
Why?
|
| Th2 Cells | 2 | 2007 | 58 | 0.150 |
Why?
|
| Organoselenium Compounds | 1 | 2017 | 10 | 0.150 |
Why?
|
| Carrier Proteins | 2 | 2014 | 305 | 0.150 |
Why?
|
| Melanoma | 1 | 2018 | 96 | 0.150 |
Why?
|
| Protein Binding | 3 | 2016 | 972 | 0.150 |
Why?
|
| Allergens | 2 | 2007 | 63 | 0.150 |
Why?
|
| Actinin | 1 | 2016 | 8 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2015 | 295 | 0.140 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2017 | 40 | 0.140 |
Why?
|
| Phospholipase C beta | 1 | 2016 | 2 | 0.140 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 4 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 186 | 0.140 |
Why?
|
| Survival Analysis | 1 | 2017 | 325 | 0.140 |
Why?
|
| Spirulina | 1 | 2016 | 1 | 0.140 |
Why?
|
| Polysaccharides | 1 | 2017 | 58 | 0.140 |
Why?
|
| Phycocyanin | 1 | 2016 | 2 | 0.140 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2016 | 33 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 127 | 0.140 |
Why?
|
| Pyrrolidines | 1 | 2016 | 29 | 0.140 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 45 | 0.140 |
Why?
|
| Epithelium | 1 | 2016 | 79 | 0.140 |
Why?
|
| Drosophila | 1 | 2017 | 144 | 0.140 |
Why?
|
| Imidazoles | 1 | 2016 | 126 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 122 | 0.130 |
Why?
|
| Azoxymethane | 1 | 2015 | 7 | 0.130 |
Why?
|
| tau Proteins | 1 | 2017 | 167 | 0.130 |
Why?
|
| Hepacivirus | 1 | 2016 | 62 | 0.130 |
Why?
|
| Endothelial Cells | 1 | 2019 | 308 | 0.130 |
Why?
|
| Endometrial Neoplasms | 1 | 2016 | 66 | 0.130 |
Why?
|
| I-kappa B Proteins | 1 | 2015 | 41 | 0.130 |
Why?
|
| Injections, Intraperitoneal | 1 | 2015 | 60 | 0.130 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 42 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 168 | 0.130 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2016 | 45 | 0.130 |
Why?
|
| Prospective Studies | 1 | 2019 | 1378 | 0.130 |
Why?
|
| Transketolase | 1 | 2015 | 2 | 0.130 |
Why?
|
| Granzymes | 1 | 2015 | 16 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 222 | 0.130 |
Why?
|
| Thapsigargin | 1 | 2014 | 7 | 0.130 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2014 | 5 | 0.130 |
Why?
|
| src Homology Domains | 1 | 2014 | 12 | 0.130 |
Why?
|
| Immunodominant Epitopes | 1 | 2015 | 27 | 0.130 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2015 | 20 | 0.130 |
Why?
|
| Antibody Formation | 1 | 2015 | 74 | 0.130 |
Why?
|
| Pregnancy | 1 | 2020 | 1549 | 0.130 |
Why?
|
| Cognition Disorders | 1 | 2017 | 233 | 0.120 |
Why?
|
| Cell Biology | 1 | 2014 | 12 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 461 | 0.120 |
Why?
|
| Immunization | 1 | 2015 | 92 | 0.120 |
Why?
|
| beta-Endorphin | 1 | 2014 | 14 | 0.120 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2014 | 9 | 0.120 |
Why?
|
| Hepatitis C | 1 | 2016 | 125 | 0.120 |
Why?
|
| Adjuvants, Immunologic | 1 | 2015 | 107 | 0.120 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 59 | 0.120 |
Why?
|
| Time Factors | 3 | 2008 | 1742 | 0.120 |
Why?
|
| Biometry | 2 | 2024 | 11 | 0.120 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 61 | 0.120 |
Why?
|
| Lens Implantation, Intraocular | 2 | 2024 | 7 | 0.120 |
Why?
|
| Corneal Topography | 2 | 2024 | 26 | 0.120 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2014 | 4 | 0.120 |
Why?
|
| Cell Communication | 2 | 2013 | 97 | 0.120 |
Why?
|
| Haptoglobins | 1 | 2014 | 10 | 0.120 |
Why?
|
| RNA-Binding Proteins | 2 | 2006 | 146 | 0.120 |
Why?
|
| Cysteine | 1 | 2014 | 98 | 0.120 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2014 | 7 | 0.120 |
Why?
|
| Clusterin | 1 | 2014 | 9 | 0.120 |
Why?
|
| Jejunum | 1 | 2014 | 8 | 0.120 |
Why?
|
| Sensory Receptor Cells | 1 | 2014 | 32 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 188 | 0.120 |
Why?
|
| Organic Anion Transporters | 1 | 2014 | 4 | 0.120 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2005 | 70 | 0.120 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 62 | 0.120 |
Why?
|
| Spleen | 3 | 2015 | 199 | 0.120 |
Why?
|
| Proteins | 2 | 2022 | 369 | 0.120 |
Why?
|
| Cornea | 2 | 2024 | 58 | 0.120 |
Why?
|
| Kidney | 1 | 2016 | 337 | 0.120 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 54 | 0.120 |
Why?
|
| Retrospective Studies | 3 | 2024 | 2026 | 0.120 |
Why?
|
| Toxicity Tests | 1 | 2014 | 43 | 0.120 |
Why?
|
| Virus Replication | 1 | 2016 | 278 | 0.120 |
Why?
|
| ROC Curve | 1 | 2014 | 138 | 0.120 |
Why?
|
| Genes, Reporter | 1 | 2014 | 136 | 0.120 |
Why?
|
| Research | 1 | 2015 | 163 | 0.110 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2013 | 22 | 0.110 |
Why?
|
| Methionine | 1 | 2013 | 30 | 0.110 |
Why?
|
| Treatment Outcome | 1 | 2017 | 1369 | 0.110 |
Why?
|
| Random Allocation | 1 | 2014 | 139 | 0.110 |
Why?
|
| Mixed Function Oxygenases | 1 | 2013 | 34 | 0.110 |
Why?
|
| Peptides | 1 | 2016 | 320 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 935 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2014 | 106 | 0.110 |
Why?
|
| Foam Cells | 1 | 2013 | 13 | 0.110 |
Why?
|
| Plasmids | 1 | 2014 | 246 | 0.110 |
Why?
|
| Oxidoreductases | 1 | 2013 | 87 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 234 | 0.110 |
Why?
|
| Actins | 1 | 2013 | 148 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 85 | 0.110 |
Why?
|
| Magnesium Oxide | 2 | 2022 | 2 | 0.110 |
Why?
|
| Protein Transport | 1 | 2013 | 302 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2017 | 318 | 0.110 |
Why?
|
| Young Adult | 2 | 2019 | 4268 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 67 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 115 | 0.100 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 42 | 0.100 |
Why?
|
| Universities | 1 | 2015 | 442 | 0.100 |
Why?
|
| Hypertrophy | 1 | 2011 | 32 | 0.100 |
Why?
|
| Atherosclerosis | 1 | 2013 | 134 | 0.100 |
Why?
|
| Peritonitis | 1 | 2011 | 9 | 0.100 |
Why?
|
| Antibodies, Neoplasm | 1 | 2011 | 16 | 0.100 |
Why?
|
| Butyrates | 1 | 2011 | 31 | 0.100 |
Why?
|
| Periodontal Ligament | 1 | 2010 | 1 | 0.100 |
Why?
|
| Receptors, Peptide | 1 | 2011 | 23 | 0.100 |
Why?
|
| Dental Pulp | 1 | 2010 | 3 | 0.100 |
Why?
|
| Liver | 1 | 2014 | 479 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 42 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1130 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2011 | 59 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2013 | 249 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2011 | 157 | 0.090 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2010 | 32 | 0.090 |
Why?
|
| Ligands | 1 | 2011 | 349 | 0.090 |
Why?
|
| Glioma | 1 | 2011 | 79 | 0.090 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2010 | 62 | 0.090 |
Why?
|
| Gene Expression | 2 | 2015 | 674 | 0.090 |
Why?
|
| Bromodeoxyuridine | 1 | 2009 | 24 | 0.090 |
Why?
|
| Mutation | 3 | 2017 | 1095 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2011 | 103 | 0.090 |
Why?
|
| Protein Kinase C | 1 | 2010 | 120 | 0.090 |
Why?
|
| Interleukin-2 | 1 | 2010 | 89 | 0.090 |
Why?
|
| Toxicity Tests, Chronic | 1 | 2009 | 2 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 111 | 0.090 |
Why?
|
| Tunicamycin | 1 | 2009 | 22 | 0.090 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2009 | 2 | 0.090 |
Why?
|
| Phosphotyrosine | 1 | 2009 | 23 | 0.080 |
Why?
|
| Phosphoserine | 1 | 2009 | 19 | 0.080 |
Why?
|
| Peptide Elongation Factors | 2 | 2006 | 11 | 0.080 |
Why?
|
| Blood Proteins | 1 | 2009 | 66 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2011 | 517 | 0.080 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2008 | 20 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 194 | 0.080 |
Why?
|
| Coculture Techniques | 3 | 2015 | 101 | 0.080 |
Why?
|
| Endopeptidase K | 1 | 2008 | 4 | 0.080 |
Why?
|
| Caseins | 1 | 2008 | 13 | 0.080 |
Why?
|
| Models, Animal | 1 | 2008 | 134 | 0.080 |
Why?
|
| Trypsin | 1 | 2008 | 38 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2017 | 269 | 0.080 |
Why?
|
| Base Sequence | 2 | 2014 | 997 | 0.080 |
Why?
|
| Cross Reactions | 2 | 2005 | 83 | 0.080 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2007 | 2 | 0.080 |
Why?
|
| Receptors, Glucagon | 1 | 2007 | 2 | 0.080 |
Why?
|
| Caveolin 1 | 1 | 2007 | 29 | 0.080 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 18 | 0.080 |
Why?
|
| Amyloid | 1 | 2008 | 54 | 0.080 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2007 | 56 | 0.080 |
Why?
|
| Antibodies | 1 | 2008 | 141 | 0.080 |
Why?
|
| Thiazoles | 1 | 2008 | 74 | 0.080 |
Why?
|
| Immunoglobulin E | 1 | 2007 | 55 | 0.070 |
Why?
|
| Ethanol | 1 | 2008 | 192 | 0.070 |
Why?
|
| Models, Chemical | 1 | 2008 | 207 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2008 | 215 | 0.070 |
Why?
|
| Testis | 1 | 2007 | 187 | 0.070 |
Why?
|
| Chick Embryo | 2 | 2017 | 74 | 0.070 |
Why?
|
| Lipids | 1 | 2007 | 235 | 0.070 |
Why?
|
| Codon | 1 | 2005 | 42 | 0.070 |
Why?
|
| RNA, Transfer | 1 | 2005 | 28 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 441 | 0.060 |
Why?
|
| Hybridomas | 1 | 2005 | 29 | 0.060 |
Why?
|
| Injections, Subcutaneous | 1 | 2005 | 33 | 0.060 |
Why?
|
| Immune Sera | 1 | 2005 | 59 | 0.060 |
Why?
|
| Germinal Center | 1 | 2005 | 10 | 0.060 |
Why?
|
| Multigene Family | 1 | 2005 | 106 | 0.060 |
Why?
|
| Adoptive Transfer | 1 | 2005 | 48 | 0.060 |
Why?
|
| Cell Adhesion | 2 | 2017 | 212 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2005 | 52 | 0.060 |
Why?
|
| Erythrocytes | 2 | 2022 | 111 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 77 | 0.060 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2005 | 57 | 0.060 |
Why?
|
| Stereoisomerism | 1 | 2005 | 167 | 0.060 |
Why?
|
| Anopheles | 1 | 2004 | 17 | 0.060 |
Why?
|
| Databases, Nucleic Acid | 1 | 2004 | 27 | 0.060 |
Why?
|
| Lymphangiogenesis | 1 | 2024 | 4 | 0.060 |
Why?
|
| Lymphatic Vessels | 1 | 2024 | 6 | 0.060 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2005 | 132 | 0.060 |
Why?
|
| Tomography, Optical Coherence | 1 | 2024 | 31 | 0.060 |
Why?
|
| Bone Marrow | 1 | 2024 | 37 | 0.060 |
Why?
|
| Aedes | 1 | 2004 | 34 | 0.060 |
Why?
|
| Optics and Photonics | 1 | 2024 | 28 | 0.060 |
Why?
|
| Liposomes | 1 | 2005 | 118 | 0.060 |
Why?
|
| Vibrissae | 1 | 2024 | 33 | 0.060 |
Why?
|
| Pancreatitis | 1 | 2003 | 17 | 0.060 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2003 | 14 | 0.060 |
Why?
|
| DNA Primers | 1 | 2004 | 286 | 0.060 |
Why?
|
| Calcinosis | 1 | 2024 | 59 | 0.060 |
Why?
|
| Visual Acuity | 1 | 2024 | 97 | 0.060 |
Why?
|
| Ovary | 2 | 2017 | 108 | 0.060 |
Why?
|
| RNA | 1 | 2005 | 241 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2005 | 681 | 0.050 |
Why?
|
| Complement C1q | 1 | 2002 | 1 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2002 | 2 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2002 | 4 | 0.050 |
Why?
|
| Calreticulin | 1 | 2002 | 7 | 0.050 |
Why?
|
| Receptor, erbB-2 | 1 | 2004 | 133 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 172 | 0.050 |
Why?
|
| Leukocyte Elastase | 1 | 2002 | 9 | 0.050 |
Why?
|
| Chromosomal Instability | 1 | 2022 | 22 | 0.050 |
Why?
|
| Bronchiectasis | 1 | 2002 | 10 | 0.050 |
Why?
|
| Cystic Fibrosis | 1 | 2002 | 18 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2015 | 251 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2016 | 182 | 0.050 |
Why?
|
| Chromosome Segregation | 1 | 2022 | 41 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2022 | 118 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 626 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 539 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2022 | 190 | 0.050 |
Why?
|
| Biological Availability | 1 | 2020 | 88 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 112 | 0.040 |
Why?
|
| Dogs | 1 | 2020 | 149 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 229 | 0.040 |
Why?
|
| Molecular Weight | 2 | 2013 | 167 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 409 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 6 | 0.040 |
Why?
|
| Transcription Factor CHOP | 1 | 2018 | 11 | 0.040 |
Why?
|
| Pluripotent Stem Cells | 1 | 2018 | 32 | 0.040 |
Why?
|
| Hawaii | 2 | 2015 | 1929 | 0.040 |
Why?
|
| Antibody Specificity | 2 | 2011 | 79 | 0.040 |
Why?
|
| Cell Death | 1 | 2019 | 267 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 114 | 0.040 |
Why?
|
| Fat Body | 1 | 2017 | 10 | 0.040 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2017 | 39 | 0.040 |
Why?
|
| Keratin-6 | 1 | 2017 | 1 | 0.040 |
Why?
|
| Carboplatin | 1 | 2017 | 13 | 0.040 |
Why?
|
| Ulva | 1 | 2017 | 7 | 0.040 |
Why?
|
| Life Cycle Stages | 1 | 2017 | 29 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 13 | 0.040 |
Why?
|
| Macrolides | 1 | 2017 | 11 | 0.040 |
Why?
|
| Presenilin-1 | 1 | 2017 | 27 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 113 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 29 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 45 | 0.040 |
Why?
|
| Maze Learning | 1 | 2017 | 105 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 65 | 0.040 |
Why?
|
| Larva | 1 | 2017 | 124 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2016 | 34 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2017 | 95 | 0.030 |
Why?
|
| Reaction Time | 1 | 2017 | 143 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 53 | 0.030 |
Why?
|
| Avoidance Learning | 1 | 2017 | 62 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2016 | 150 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2016 | 75 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2016 | 91 | 0.030 |
Why?
|
| Autophagy | 1 | 2017 | 116 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 142 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 196 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 408 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2016 | 153 | 0.030 |
Why?
|
| Blood | 1 | 2015 | 37 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 108 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2015 | 29 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 131 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 433 | 0.030 |
Why?
|
| Education, Graduate | 1 | 2014 | 27 | 0.030 |
Why?
|
| HIV Infections | 1 | 2008 | 2303 | 0.030 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2014 | 12 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 208 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 2014 | 27 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 86 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2014 | 66 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 360 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 311 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2015 | 103 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 502 | 0.030 |
Why?
|
| Gelatin | 1 | 2013 | 15 | 0.030 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2014 | 80 | 0.030 |
Why?
|
| RNA Stability | 1 | 2013 | 26 | 0.030 |
Why?
|
| Nanocapsules | 1 | 2013 | 17 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2013 | 35 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2013 | 47 | 0.030 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2013 | 71 | 0.030 |
Why?
|
| Fowlpox virus | 1 | 2013 | 2 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 69 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 1502 | 0.030 |
Why?
|
| Particle Size | 1 | 2013 | 215 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2013 | 109 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2013 | 62 | 0.030 |
Why?
|
| Mitochondria | 1 | 2016 | 487 | 0.030 |
Why?
|
| Macrophages, Alveolar | 2 | 2002 | 34 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2014 | 308 | 0.030 |
Why?
|
| Monocytes | 1 | 2014 | 257 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2013 | 95 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2011 | 6 | 0.020 |
Why?
|
| Caspase 7 | 1 | 2011 | 16 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2011 | 11 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 19 | 0.020 |
Why?
|
| Immunocompetence | 1 | 2011 | 8 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 55 | 0.020 |
Why?
|
| Vaccination | 1 | 2013 | 288 | 0.020 |
Why?
|
| Immunity, Humoral | 1 | 2011 | 24 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2011 | 30 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2011 | 61 | 0.020 |
Why?
|
| Regeneration | 1 | 2010 | 20 | 0.020 |
Why?
|
| Sheep | 1 | 2010 | 72 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2010 | 48 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2011 | 207 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 252 | 0.020 |
Why?
|
| Glycolipids | 1 | 2009 | 9 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 1175 | 0.020 |
Why?
|
| Transferrin | 1 | 2009 | 40 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2009 | 19 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 239 | 0.020 |
Why?
|
| Glycosylation | 1 | 2009 | 100 | 0.020 |
Why?
|
| Binding Sites | 1 | 2010 | 651 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2009 | 83 | 0.020 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2008 | 10 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2007 | 6 | 0.020 |
Why?
|
| Benzothiazoles | 1 | 2008 | 21 | 0.020 |
Why?
|
| Interleukins | 1 | 2007 | 29 | 0.020 |
Why?
|
| Pulmonary Fibrosis | 1 | 2007 | 31 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 550 | 0.020 |
Why?
|
| Casein Kinase II | 1 | 2007 | 15 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 208 | 0.020 |
Why?
|
| Swine | 1 | 2007 | 184 | 0.020 |
Why?
|
| Cattle | 1 | 2008 | 477 | 0.020 |
Why?
|
| Nuclear Export Signals | 1 | 2006 | 2 | 0.020 |
Why?
|
| Genetic Code | 1 | 2006 | 7 | 0.020 |
Why?
|
| Nuclear Localization Signals | 1 | 2006 | 17 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2006 | 59 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2006 | 143 | 0.020 |
Why?
|
| Trypsin Inhibitor, Kazal Pancreatic | 1 | 2003 | 5 | 0.010 |
Why?
|
| Pedigree | 1 | 2003 | 79 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2004 | 269 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2002 | 96 | 0.010 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2002 | 11 | 0.010 |
Why?
|
| Neutrophils | 1 | 2002 | 131 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 484 | 0.010 |
Why?
|
| Adolescent | 1 | 2002 | 5363 | 0.010 |
Why?
|